MedPage Today on MSN

Autoimmune Anemia Is the Latest Condition Found Responsive to CAR-T Therapy

Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...
The American Journal of Managed Care

What Would Make Therapy Last? How About 2 Targets Each on B Cells and T Cells?

The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...

First leukaemia patient to receive pioneering treatment on NHS says it is 'very sci-fi'

The first leukaemia patient to receive a breakthrough treatment since it was made available on the NHS has said it was ...
Healio

‘Complete eradication’ of B cells drives remission after autoimmune CAR T-cell therapy

Please provide your email address to receive an email when new articles are posted on . A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the ...

Artiva Biotherapeutics: Upcoming Data Presentations May Bring Them Out Of Being Ignored

Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...

Hodgkin’s vs. Non-Hodgkin’s Lymphoma: Causes, Symptoms, and Treatment Protocols

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...
FierceBiotech

Cabaletta CAR-T wipes out B cells without preconditioning in small autoimmune trial

Cabaletta Bio’s CAR-T cell therapy has eliminated the overreactive B cells of two patients with an autoimmune disease without preconditioning chemotherapy, pleasing investors and analysts while ...
GEN

Immune Cell Profiling in Type 1 Diabetes Identifies Changes in Memory T Cells and B Cells

Scientists analyzing human and mouse pancreatic lymph nodes (PLNs) and spleens have identified a distinct subset of CD4 memory helper T cells associated with type 1 diabetes (T1D). Reported by ...